- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Carfilzomib, Lenalidomide, Dexamethasone, Belantamab Mafodotin
Total 500 results
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Celgene; The Leukemia and Lymphoma Society; Multiple Myeloma... and other collaboratorsCompletedSmoldering Multiple Myeloma | Smoldering MyelomaUnited States
-
Bristol-Myers SquibbAbbVieCompleted
-
University of Heidelberg Medical CenterCompleted
-
Merck Sharp & Dohme LLCTerminated
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPlasma Cell Myeloma | Smoldering Plasma Cell Myeloma | Indolent Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Nantes University HospitalJanssen PharmaceuticaNot yet recruiting
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Belgium, Germany, Netherlands, Israel, Spain, Saudi Arabia, France
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompletedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Bristol-Myers SquibbCompleted
-
Michaela LiedtkeCelgene CorporationCompletedMultiple MyelomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
Medical College of WisconsinRecruiting
-
Omar Nadeem, MDJanssen, LPRecruitingMultiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, France, United Kingdom, Belgium, Germany, Israel, Australia, Sweden, Canada, Netherlands, Austria, Ireland, Denmark
-
Massachusetts General HospitalMultiple Myeloma Research ConsortiumActive, not recruitingMultiple MyelomaUnited States
-
MorphoSys AGCompletedMultiple MyelomaAustria, Germany
-
Bristol-Myers SquibbCompleted
-
University of ArkansasWithdrawn
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); City of Hope Medical Center and other collaboratorsCompletedRecurrent Plasma Cell MyelomaUnited States
-
Washington University School of MedicineCompleted
-
University of Heidelberg Medical CenterSanofi; KKS Netzwerk; Deutsche Studiengruppe Multiples Myelom (DSMM)Recruiting
-
University of Heidelberg Medical CenterJanssen Research & Development, LLC; Deutsche Studiengruppe Multiples Myelom...Recruiting
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaGermany, Korea, Republic of, Belgium, Israel, Australia, United Kingdom, France, Sweden, Spain, Turkey, Italy, Japan, Czechia, Brazil, Netherlands, Poland, Portugal, Switzerland, Norway, Greece, China, Canada
-
Jacob Laubach, MDSanofiRecruitingMultiple Myeloma | Autologous Stem Cell Transplant | Newly Diagnosed Multiple Myeloma (NDMM)United States
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Israel, Czechia, Turkey, Germany, United Kingdom, Netherlands, Japan, France, Poland, Spain, Brazil
-
TakedaActive, not recruiting
-
SanofiActive, not recruitingPlasma Cell MyelomaMexico, Sweden, Poland, France, Czechia, Greece, Taiwan, Lithuania, Portugal, Spain, Australia, Italy, New Zealand, Russian Federation, Turkey, Japan, United States, Belgium, China, Denmark, Germany
-
University of ArkansasWithdrawn
-
Dana-Farber Cancer InstituteBristol-Myers SquibbNo longer availableMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Mayo ClinicCompletedMultiple Myeloma | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
SanofiActive, not recruitingRelapsed/Refractory Multiple MyelomaAustralia, Czechia, Brazil, Japan, Greece, Portugal
-
Peter MacCallum Cancer Centre, AustraliaCelgene CorporationUnknown
-
University of WashingtonGenzyme, a Sanofi CompanyRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited Kingdom, United States, France, Netherlands, Denmark
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaHong Kong, Korea, Republic of, Singapore
-
Gruppo Italiano Studio LinfomiUnknown
-
National University Hospital, SingaporeNational University of SingaporeRecruiting
-
Vanderbilt-Ingram Cancer CenterCompleted
-
Hackensack Meridian HealthAmgenSuspendedMultiple MyelomaUnited States
-
Hackensack Meridian HealthKaryopharm Therapeutics IncRecruitingMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Germany, Spain, Denmark, Netherlands, Finland, Italy
-
Raija SilvennoinenTakeda; Celgene; Nordic Myeloma Study GroupActive, not recruitingMultiple MyelomaNorway, Sweden, Finland, Lithuania
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
Millennium Pharmaceuticals, Inc.Completed